This selection from the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology
focuses on considerations for the comprehensive care of AYA patients with cancer …

This selection from the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology
focuses on treatment and management considerations for AYA patients with cancer …

Cancer is the leading cause of death among the adolescent and young adult (AYA)
population, excluding homicide, suicide, or unintentional injury. AYA patients should be …

Purpose This consensus-based position statement on behalf of the LIVESTRONG Young
Adult Alliance (Alliance) offers recommendations to enhance oncologic care of adolescent …

Adolescents and young adults (AYAs) comprise a unique cohort of patients of age 15-39
years; cancer diagnoses in this population account for roughly 5% of all cancer diagnoses …

In 1996, W. Archie Bleyer made the seminal observation that adolescents, age 15 to 19
years, had not benefited from cancer therapy improvements to the same extent as children …

Whereas adolescents with cancer as a group used to have a better prognosis than children
with malignant disease, trends suggest that the overall survival of 15-to 19-year-olds is now …

Over the past few decades, 5‐year cancer survival has steadily improved for all adolescents
and young adults (AYA, 15–39 years at diagnosis) combined. While encouraging, this …

Driven by reports of unmet clinical needs and lack of survival improvement, programs for
adolescents and young adults (AYAs) with cancer have become increasingly common …

Adolescent and young adult (AYA) patients with cancer are a unique category of patients
who, depending on age at time of diagnosis, might receive treatment from oncologists …